It upregulates cyp4a12, beta-1 adrenergic receptor (adrb1), and cyp2j5, while downregulates cyp2c29, ace2 gene expression, leading to cardiac diseases and drug-induced cardiotoxicity. This evidence concerns the gene ACE2 and heart disorder.